Medicover AB (publ) (OTCMKTS:MCVEF – Get Free Report) and The Pennant Group (NASDAQ:PNTG – Get Free Report) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, dividends, analyst recommendations and valuation.
Profitability
This table compares Medicover AB (publ) and The Pennant Group’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Medicover AB (publ) | N/A | N/A | N/A |
| The Pennant Group | 2.93% | 10.33% | 4.20% |
Analyst Recommendations
This is a summary of current ratings and recommmendations for Medicover AB (publ) and The Pennant Group, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Medicover AB (publ) | 0 | 0 | 0 | 0 | 0.00 |
| The Pennant Group | 0 | 1 | 7 | 0 | 2.88 |
Earnings and Valuation
This table compares Medicover AB (publ) and The Pennant Group”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Medicover AB (publ) | N/A | N/A | N/A | N/A | N/A |
| The Pennant Group | $947.71 million | 1.45 | $29.58 million | $0.90 | 43.78 |
The Pennant Group has higher revenue and earnings than Medicover AB (publ).
Institutional and Insider Ownership
85.9% of The Pennant Group shares are owned by institutional investors. 6.9% of The Pennant Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Summary
The Pennant Group beats Medicover AB (publ) on 9 of the 9 factors compared between the two stocks.
About Medicover AB (publ)
Medicover AB (publ) provides healthcare and diagnostic services in Poland, Sweden, and internationally. The company’s Healthcare services includes service outpatient and inpatient care; dental services; other services, including non-medical related services, such as sports memberships, benefit cards, and optics, as well as wellness services; hospital care; and preventive care. Its Diagnostic services comprise various tests, including allergy and autoimmune diagnostics, bacteriology, parasitology, biochemistry and immunochemistry, blood group diagnostics/transfusion medicine, tumour markers, clinical chemistry, cytology, haematology, histopathology, human genetics, hygiene, immunology and immunochemistry, infectious diseases, microbiology, molecular biology, and pharmacology/toxicology. It serves corporate, individuals, and public payers. Medicover AB (publ) was founded in 1995 and is headquartered in Stockholm, Sweden.
About The Pennant Group
The Pennant Group, Inc. provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families. It also provides senior living services, such as residential accommodations, activities, meals, housekeeping, and assistance in the activities of daily living to seniors who are independent or who require some support. The company operates home health, hospice, and home care agencies, as well as senior living communities throughout Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The Pennant Group, Inc. was incorporated in 2019 and is headquartered in Eagle, Idaho.
Receive News & Ratings for Medicover AB (publ) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicover AB (publ) and related companies with MarketBeat.com's FREE daily email newsletter.
